Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antidepressant effect of ketamine during ECT.

Literature DB >> 15994728

Antidepressant effect of ketamine during ECT.

Robert Ostroff, Marbiela Gonzales, Gerard Sanacora.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2005 PMID： 15994728 DOI： 10.1176/appi.ajp.162.7.1385

Source DB: PubMed Journal: Am J Psychiatry ISSN： 0002-953X Impact factor: 18.112

Keyword Cloud
Cited

× No keyword cloud information.

24 in total

Review 1. Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.

Authors: Mark J Niciu; Ioline D Henter; David A Luckenbaugh; Carlos A Zarate; Dennis S Charney
Journal: Annu Rev Pharmacol Toxicol Date: 2014 Impact factor: 13.820

2. Lack of persistent effects of ketamine in rodent models of depression.

Authors: Piotr Popik; Tomasz Kos; Magdalena Sowa-Kućma; Gabriel Nowak
Journal: Psychopharmacology (Berl) Date: 2008-05-07 Impact factor: 4.530

Review 3. Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors: Xiaohua Li; Mark A Frye; Richard C Shelton
Journal: Neuropsychopharmacology Date: 2011-09-07 Impact factor: 7.853

4. Post-electroconvulsive therapy recovery and reorientation time with methohexital and ketamine: a randomized, longitudinal, crossover design trial.

Authors: Tony Yen; Mohamad Khafaja; Nicholas Lam; James Crumbacher; Ronald Schrader; John Rask; Mary Billstrand; Jacob Rothfork; Christopher C Abbott
Journal: J ECT Date: 2015-03 Impact factor: 3.635

Antidepressant effect of ketamine during ECT.

Review 1. Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.

2. Lack of persistent effects of ketamine in rodent models of depression.

Review 3. Review of pharmacological treatment in mood disorders and future directions for drug development.

4. Post-electroconvulsive therapy recovery and reorientation time with methohexital and ketamine: a randomized, longitudinal, crossover design trial.

5. S -ketamine compared to etomidate during electroconvulsive therapy in major depression.

6. Ketofol in electroconvulsive therapy anesthesia: two stones for one bird.

7. Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital.

Review 8. Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders.

Review 9. Novel targets for antidepressant therapies.

10. Ketamine exposure in adult mice leads to increased cell death in C3H, DBA2 and FVB inbred mouse strains.